Eyenovia logo

Eyenovia Share Price Today

(NASDAQ: EYEN)

Eyenovia share price is $1.59 & ₹138.28 as on 6 Mar 2025, 2.30 'hrs' IST

$1.59

0.01

(0.63%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Eyenovia share price in Dollar and Rupees. Guide to invest in Eyenovia stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Eyenovia, along with analyst recommendations, forecasts, and comprehensive financials.

Eyenovia share price movements

  • Today's Low: $1.50
    Today's High: $1.62

    Day's Volatility :7.41%

  • 52 Weeks Low: $1.43
    52 Weeks High: $178.40

    52 Weeks Volatility :99.2%

Eyenovia (EYEN) Returns

PeriodEyenovia IncIndex (Russel 2000)
3 Months
-79.62%
0.0%
6 Months
-96.15%
0.0%
1 Year
-98.83%
0.0%
3 Years
-99.31%
-11.6%

Eyenovia (EYEN) Key Statistics

in dollars & INR

Previous Close
$1.58
Open
$1.53
Today's High
$1.62
Today's Low
$1.5
Market Capitalization
$3.2M
Today's Volume
$5.0K
52 Week High
$178.4
52 Week Low
$1.43
Revenue TTM
$31.8K
EBITDA
$-35.6M
Earnings Per Share (EPS)
$-56.2
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-388.03%

How to invest in Eyenovia Stock (EYEN) from India?

It is very easy for Indian residents to invest directly in Eyenovia from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Eyenovia stock in both Indian Rupees (INR) and US Dollars (USD). Search for Eyenovia or EYEN on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Eyenovia or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Eyenovia shares which would translate to 0.547 fractional shares of Eyenovia as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Eyenovia, in just a few clicks!

Returns in Eyenovia (EYEN) for Indian investors in Rupees

The Eyenovia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Eyenovia investment value today

Current value as on today

₹6,135

Returns

₹93,865

(-93.86%)

Returns from Eyenovia Stock

₹98,827 (-98.83%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Eyenovia (EYEN)

-83.84%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Eyenovia Shares from India has dropped by -83.84% over the past 30 days, indicating reduced transactional activity.

-70%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Eyenovia Stock from India on INDmoney has decreased by -70% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Eyenovia

  • Geode Capital Management, LLC

    0.33%

  • Lasry Marc

    0.33%

  • Diametric Capital, LP

    0.09%

  • State Street Corp

    0.08%

  • SkyView Investment Advisors, LLC

    0.06%

  • BlackRock Inc

    0.05%

Analyst Recommendation on Eyenovia

Buy

    90%Buy

    10%Hold

    0%Sell

Based on 10 Wall street analysts offering stock ratings for Eyenovia(by analysts ranked 0 to 5 stars)

Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
9
9
9
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Eyenovia Stock (EYEN)

What analysts predicted

Upside of 25.79%

Target:

$2.00

Current:

$1.59

Insights on Eyenovia Stock (Ticker Symbol: EYEN)

  • Price Movement

    In the last 1 month, EYEN stock has moved down by -33.6%
  • EYEN vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 161.2%
  • EYEN vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 147.0%
  • Price to Sales

    ForEYEN every $1 of sales, investors are willing to pay $33.6, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Eyenovia Technicals Summary

Sell

Neutral

Buy

Eyenovia is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Eyenovia (EYEN) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Eyenovia Inc logo
-41.04%
-96.15%
-98.83%
-99.31%
-99.44%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Eyenovia Inc logo
NA
NA
NA
-49.6
-3.88
-0.8
NA
3.45
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Eyenovia Inc logo
Buy
$3.2M
-99.44%
NA
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Eyenovia

Eyenovia, Inc., a commercial-stage ophthalmic pharmaceutical technology company, engages in developing a pipeline of microdose array print therapeutics. It focuses on commercializing Mydcombi (tropicamide and phenylephrine HCL ophthalmic spray) for inducing mydriasis for routine diagnostic procedures and in conditions where short term pupil dilation is desired, and clobetasol propionate ophthalmic suspension for the treatment of post-operative pain and inflammation following ocular surgery. The company is also developing the Optejet delivery system for use in combination with its drug-device therapeutic programs and for out-licensing for use in combination with therapeutics for additional indications. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine, MicroLine, and Mydcombi in China and South Korea; and Senju Pharmaceutical Co., Ltd. to develop and commercialize MicroPine, MicroLine, and Mydcombi. The company has agreement with Formosa Pharmaceuticals. Inc. for Co-Development of Clobetasol Propionate Ophthalmic Suspension (0.05%) for the Treatment of Acute Dry Eye Disease in the U.S. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is based in New York, New York.
Organization
Eyenovia
Employees
57
CEO
Mr. Michael M. Rowe
Industry
Health Technology

Management People of Eyenovia

NameTitle
Mr. Michael M. Rowe
CEO, President & Director
Dr. Tsontcho Ianchulev M.D., M.P.H., MPH
Co-Founder & Executive Director
Mr. Bren Kern
COO & Corporate VP
Mr. Andrew D. Jones
CFO, Secretary & Treasurer
Mr. Tony Cardinale
Vice President of Sales
Mr. Norbert Lowe
Senior Vice President of Commercial Operations
Mr. Enrico Brambilla
Senior Vice President of R&D
Alexander Lobo
Investor Contact

Important FAQs about investing in EYEN Stock from India :

What is Eyenovia share price today?

Eyenovia share price today stands at $1.59, Open: $1.53 ; Previous Close: $1.58 ; High: $1.62 ; Low: $1.50 ; 52 Week High: $178.40 ; 52 Week Low: $1.43.

The stock opens at $1.53, after a previous close of $1.58. The stock reached a daily high of $1.62 and a low of $1.50, with a 52-week high of $178.40 and a 52-week low of $1.43.

Can Indians buy Eyenovia shares?

Yes, Indians can invest in the Eyenovia (EYEN) from India.

With INDmoney, you can buy Eyenovia at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Eyenovia at zero transaction cost.

How can I buy Eyenovia shares from India?

It is very easy to buy Eyenovia from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Eyenovia (EYEN) be purchased?

Yes, you can buy fractional shares of Eyenovia with INDmoney app.

What are the documents required to start investing in Eyenovia stocks?

To start investing in Eyenovia, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Eyenovia Stock (EYEN)?

Today’s highest price of Eyenovia (EYEN) is $1.62.

Today’s lowest price of Eyenovia (EYEN) is $1.50.

What is today's market capitalisation of Eyenovia?

Today's market capitalisation of Eyenovia EYEN is 3.2M

What is the 52 Week High and Low Range of Eyenovia Stock (EYEN)?

  • 52 Week High

    $178.40

  • 52 Week Low

    $1.43

What are the historical returns of Eyenovia (EYEN)?

  • 1 Month Returns

    -41.04%

  • 3 Months Returns

    -96.15%

  • 1 Year Returns

    -98.83%

  • 5 Years Returns

    -99.44%

Who is the Chief Executive Officer (CEO) of Eyenovia ?

Mr. Michael M. Rowe is the current Chief Executive Officer (CEO) of Eyenovia.